Sorry your transaction was not accepted.
Click here to go back to checkout page.
Click here to go back to checkout page.
Updating...
Inflammatory Breast Cancer Research Foundation
Committed To Finding The Cause!
Focusing on Research and Awareness
Site Search
Newsletter Signup
- Email Privacy Policy
- Brochures and Bookmarks
- Contact Us
- Discussions and Newsletter
- Frequently Asked Questions
- Inflammatory Breast Cancer Research Foundation BioBank
- Grants Awarded
- IBC in History
- IBC in Our Own Words
- IBC in the Media
- IBC Mini Symposium
- IBC Slide Presentation
- National Cancer Institute Dictionary of Cancer Terms
- National Cancer Institute Drug Dictionary
- NCCN® Clinical Practice Guidelines For Inflammatory Breast Cancer
- Selected Additional Resources
Breast Cancer Clinical Trials- Multicentric Randomized Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus 5-fluorouracil, Leucovorin, Irinotecan and Oxaliplatin (mFolfirinox) in Patients With Resected Pancreatic Adenocarcinoma February 1, 2012
- A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer February 1, 2012
- Donor Atorvastatin Calcium in Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Donor Peripheral Blood Stem Cell Transplant January 31, 2012
- A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer January 30, 2012
- Digital Breast Tomosynthesis Versus Digital Mammography: A National Multicenter Trial January 29, 2012
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer January 27, 2012
- Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms January 27, 2012
- A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis January 26, 2012
- Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer January 25, 2012
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors January 25, 2012